Skip to main content

Advertisement

Log in

Construction of a lentiviral vector for RNA interference of human VIM gene and its silencing effect in pancreatic cancer cells

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To construct a lentiviral expression vector for RNA interference (RNAi) of human VIM gene; and assess its gene silencing effect in pancreatic cancer cell line Panc-1.

Methods

Three pairs of human VIM gene short hairpin RNA (shRNA) sequences were designed using a software available on-line and one pair came from document. After synthesis and annealing, four double-stranded oligonucleotides (dsOligo) were cloned into the pGCL-GFP/U6 plasmid, which were subsequently confirmed by polymerase chain reaction (PCR) and DNA sequencing analysis. Real-time PCR and Western-blotting were used to screen the effective pGCL-GFP-shRNA plasmid in 293T cells, then the most effective one was packed into the recombinant lentivirus Lv-VIM-shRNA with lentiviral packing materials pHelper 1.0 and pHelper 2.0 in 293T cells. The titer of lentivirus was determined by hole-by-dilution titer assay. The silencing effect of Lv-VIM-shRNA in Panc-1 cells were validated by real-time PCR and Western-blotting.

Results

An effective Lv-VIM-shRNA was successfully constructed. The titer of lentivirus was determined on 2 × 109 TU/mL. The expressions of VIM mRNA and vimentin were down-regluated in the Panc-1 cells infected with Lv-VIM-shRNA.

Conclusion

An effective Lv-VIM-shRNA could inhibit the expression of VIM gene in Panc-1 cells in vitro, which provides a tool for investigating the role of VIM gene in the signaling pathway involved in tumorigenesis and progression of pancreatic cancer and searching new therapeutic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Guo X, Cui Z. Current diagnosis and treatment of pancreatic cancer in China. Pancreas, 2005, 31: 13–22.

    Article  PubMed  CAS  Google Scholar 

  2. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer, 2002, 2: 897–909.

    Article  PubMed  CAS  Google Scholar 

  3. Chen L, Liu Q, Qin R, et al. Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro. Int J Mol Med, 2005, 15: 617–626.

    PubMed  CAS  Google Scholar 

  4. Du ZY, Qin RY, Xia W, et al. Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts. World J Gastroenterol, 2005, 11: 516–520.

    PubMed  CAS  Google Scholar 

  5. Kumar M, Liu ZR, Thapa L, et al. Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts. Carcinogenesis, 2004, 25: 2075–2081.

    Article  PubMed  CAS  Google Scholar 

  6. Feng Y, Huang T, Gao J, et al. Inhibition of metastatic progression of SSTR2 gene transfection mediated by adenovirus in human pancreatic carcinoma cells. J Huazhong Univ Sci Technolog Med Sci, 2006, 26: 68–71.

    PubMed  CAS  Google Scholar 

  7. McInroy L, Määttä A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun, 2007, 360: 109–114.

    Article  PubMed  CAS  Google Scholar 

  8. Wang N, Stamenovic D. Mechanics of vimentin intermediate filaments. J Muscle Res Cell Motil, 2002, 23: 535–540.

    Article  PubMed  Google Scholar 

  9. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol, 2006, 7: 131–142.

    Article  PubMed  CAS  Google Scholar 

  10. Paccione RJ, Miyazaki H, Patel V, et al. Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol Cancer Ther, 2008, 7: 2894–2903.

    Article  PubMed  CAS  Google Scholar 

  11. Wei J, Xu G, Wu M, et al. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res, 2008, 28: 327–334.

    PubMed  CAS  Google Scholar 

  12. Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res, 2004, 10: 4125–4133.

    Article  PubMed  CAS  Google Scholar 

  13. Shah AN, Summy JM, Zhang J, et al. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol, 2007, 14: 3629–3637.

    Article  PubMed  Google Scholar 

  14. Ohrt T, Schwille P. siRNA modifications and sub-cellular localization: a question of intracellular transport? Curr Pharm Des, 2008, 14: 3674–3685.

    Article  PubMed  CAS  Google Scholar 

  15. Blesch A. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods, 2004, 33: 164–172.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renyi Qin.

Additional information

Supported by a grant from the National Natural Science Foundation of China (No. 30600592).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, J., Shen, M., Qin, R. et al. Construction of a lentiviral vector for RNA interference of human VIM gene and its silencing effect in pancreatic cancer cells. Chin. -Ger. J. Clin. Oncol. 8, 145–149 (2009). https://doi.org/10.1007/s10330-009-0017-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-009-0017-7

Key words

Navigation